Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-03-21

FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN, a premixed insulin lispro product, to be delivered via the KWIKPEN device by Eli Lilly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUMALOG MIX50/50 KWIKPEN (Insulin lispro)

Snippet

SUPPL AP for HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO)